Agrochemical manufacturer GSP Crop Science has reported a 19.5% year-on-year jump in consolidated revenue from operations to Rs 5,584 million for the second quarter of FY27, even as rising input costs, supply-side challenges and a weaker product mix dragged down profitability.
The company's unaudited financial results for the quarter and half year ended September 30, 2026, revealed a divergence between revenue growth and earnings performance, with EBITDA declining 21% to Rs 736 million in Q2FY27, compared with Rs 932 million in the corresponding quarter last year.
Profit after tax (PAT) also came under pressure, falling 23.7% year-on-year to Rs 446 million from Rs 585 million. EBITDA margin contracted sharply to 13.2% from 19.9% a year ago, while PAT margin slipped to 8% from 12.5%.
For the first half of FY27, revenue from operations rose 11.9% to Rs 9,444 million against Rs 8,443 million in H1FY26. However, EBITDA declined 14.3% to Rs 1,161 million, while PAT fell 12.4% to Rs 710 million.
Gross profit offered some support, increasing 2.6% to Rs 1,932 million during the quarter and 5.5% to Rs 3,356 million in the first half. However, the gross profit margin narrowed to 34.6% in Q2FY27 from 40.3% in the year-ago quarter.
The company flagged uneven rainfall patterns across the country as a key challenge for the agricultural sector. Rainfall shortfalls in southern and eastern India, coupled with excess rainfall in certain regions, created varied difficulties for farmers during the season.
The company also pointed to the potential impact of El Niño, which is expected to peak in November. Below-normal rainfall anticipated during October–December could weigh on rabi sowing activity and, in turn, influence demand for crop-protection products.
Despite the challenging operating environment, GSP Crop Science said revenue growth across key products was primarily driven by improved realisations.
The company acknowledged continued pressure on year-on-year margins, citing higher raw material procurement costs, supply-related challenges and lower sales of high-margin products. However, sequential EBITDA margin improved, reflecting the impact of cost-optimisation measures.
GSP Crop Science is also sharpening its focus on research and development to strengthen its product portfolio. Its strategy centres on differentiated formulations and patented product introductions aimed at meeting evolving crop-protection requirements.
The increase in other income during H1FY27 was primarily driven by gains from the sale of a fixed asset and foreign exchange gains.
With revenue continuing to expand but profitability facing pressure, the company's ability to manage input costs, improve its product mix and scale up differentiated offerings will remain important factors shaping its financial performance in the coming quarters.